A person living with diabetes who needs multiple daily insulin injections and has access to a smartphone and suitable applications might consider smart pens, caps or buttons as an alternative to insulin pumps
OTC weight-loss supplements marketed as GLP-1 alternatives contain different ingredients entirely, and clinical evidence does not support equivalent outcomes to prescription GLP-1 receptor agonists
It is not intended for human consumption, therapeutic use, veterinary use, diagnostic use or clinical application
Manually calculating your injection volume can be confusing and prone to error
No claims are made regarding biological activity, safety, efficacy, or medical benefit
The precise administration of vital nutrients ensures no waiting time between fluid infusion and nutrient absorption